DEVICE SUBMISSION USER FEES WILL BE CUT 20-25% IN REVISED DRAFT BILL, FDAers SAY; CURRENTLY PENDING APPLICATIONS WOULD BE EXEMPT FROM RETROACTIVE FEES
This article was originally published in The Gray Sheet
Executive Summary
Proposed device user fees for premarket submissions will be reduced 20-25% in an upcoming revision to draft user fee legislation, according to FDA staffers.